Matches in Wikidata for { <http://www.wikidata.org/entity/Q93008933> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q93008933 description "article scientifique publié en 2019" @default.
- Q93008933 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q93008933 description "scientific article published on 25 June 2019" @default.
- Q93008933 description "wetenschappelijk artikel" @default.
- Q93008933 description "наукова стаття, опублікована 25 червня 2019" @default.
- Q93008933 name "High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy" @default.
- Q93008933 name "High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy" @default.
- Q93008933 type Item @default.
- Q93008933 label "High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy" @default.
- Q93008933 label "High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy" @default.
- Q93008933 prefLabel "High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy" @default.
- Q93008933 prefLabel "High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy" @default.
- Q93008933 P1433 Q93008933-48F47844-4193-44E8-9598-2058ACE4EAC0 @default.
- Q93008933 P1476 Q93008933-7171219C-92B4-4378-BB7A-8BD740ED916C @default.
- Q93008933 P2093 Q93008933-1A4751CC-07C5-4967-847E-81EF7C89BDB6 @default.
- Q93008933 P2093 Q93008933-23341011-D914-4A8D-9647-CEEFFEEC5EC5 @default.
- Q93008933 P2093 Q93008933-4F20894E-E020-4934-A7F1-F6745CED8034 @default.
- Q93008933 P2093 Q93008933-6B1203C9-A33A-4E4F-A953-16158804CAF6 @default.
- Q93008933 P2093 Q93008933-849949DC-5A6D-474C-981F-3F6218FB4E2B @default.
- Q93008933 P2093 Q93008933-8F307F93-825C-4657-BA81-FAEBB6013D67 @default.
- Q93008933 P304 Q93008933-62B0F226-4AD0-402C-8410-5AF72F4D7891 @default.
- Q93008933 P31 Q93008933-2708B13C-926C-41CF-98D4-4AFCEA2DE8D0 @default.
- Q93008933 P356 Q93008933-C4105509-013E-465C-A1F4-36936F5D56FB @default.
- Q93008933 P433 Q93008933-6FF59A4C-2B82-44F4-86A9-B5A6325EEBC4 @default.
- Q93008933 P478 Q93008933-CBDD850E-B72A-4E12-8A2C-CDDF43609D5E @default.
- Q93008933 P50 Q93008933-48142051-D1AD-4AC6-A3E2-E877DE14214D @default.
- Q93008933 P577 Q93008933-9DBEA9A3-C8D9-4635-901F-4349A0ED2B16 @default.
- Q93008933 P698 Q93008933-42AF6CFF-8F68-4C6F-8AD0-4AEAA4C647A6 @default.
- Q93008933 P921 Q93008933-78E3DF3B-62FC-4B5B-9BA8-E715E37DA8DE @default.
- Q93008933 P356 10428194.2019.1581936 @default.
- Q93008933 P698 31237178 @default.
- Q93008933 P1433 Q6534493 @default.
- Q93008933 P1476 "High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy" @default.
- Q93008933 P2093 "Catherine Cheung" @default.
- Q93008933 P2093 "Courtney Tate" @default.
- Q93008933 P2093 "Devinder Gill" @default.
- Q93008933 P2093 "Melinda Burgess" @default.
- Q93008933 P2093 "Nigel A McMillan" @default.
- Q93008933 P2093 "Peter Mollee" @default.
- Q93008933 P304 "2563-2567" @default.
- Q93008933 P31 Q13442814 @default.
- Q93008933 P356 "10.1080/10428194.2019.1581936" @default.
- Q93008933 P433 "10" @default.
- Q93008933 P478 "60" @default.
- Q93008933 P50 Q57190898 @default.
- Q93008933 P577 "2019-06-25T00:00:00Z" @default.
- Q93008933 P698 "31237178" @default.
- Q93008933 P921 Q1088156 @default.